Continuing education

Advanced Masterclasses

Staying current as the evidence evolves

Learning in this field never stands still. The Institute will regularly release advanced online Masterclasses examining important developments in peptide science and clinical research.

Coming soonDates to be announcedPricing to be announced

About this programme

A continuing-education series for practitioners who have completed Institute programmes or hold equivalent background. Masterclasses are concise, focused and updated as the literature evolves.

Learning objectives

  • Stay current with high-impact developments in peptide science.
  • Critically discuss landmark trials and emerging controversies.
  • Apply updated evidence within existing governance frameworks.

Programme outline

  • Emerging scientific discoveries
  • Landmark clinical trials
  • Individual peptide families
  • Clinical controversies
  • Journal reviews
  • Expert case discussions
  • Regulatory developments
  • Advances in ageing science

Format

Short online Masterclasses, released on an ongoing basis.

Audience

Practitioners with prior Institute learning or equivalent background.

Prerequisites

Recommended: completion of an Institute foundation programme.

Dates & pricing

Enrolment dates, fees and admissions criteria will be published in due course. To register interest, please use the enquiry form on the home page.

This programme is educational in nature and written for a United States audience. It does not promote, market or recommend any drug, biologic, device or dietary supplement, and it does not provide prescribing protocols. The U.S. regulatory status of individual peptides — including approval, investigational status, and eligibility for pharmacy compounding under Sections 503A/503B — is determined by the FDA and may change over time. Clinical decisions remain the responsibility of individual U.S.-licensed practitioners operating within their state scope of practice and applicable federal and state law. See our full regulatory disclaimer.